Procter & Gamble Health Limited (NSE:PGHL)
India · Delayed Price · Currency is INR 6,066.00
-19.50 (-0.32%)
Nov 4, 2025, 3:30 PM IST
Procter & Gamble Health Market Cap
Procter & Gamble Health has a market cap or net worth of 100.54 billion as of November 4, 2025. Its market cap has increased by 15.22% in one year.
Market Cap
100.54B
Enterprise Value
98.74B
Revenue
12.73B
Ranking
n/a
PE Ratio
33.45
Stock Price
6,066.00
Market Cap Chart
Since June 14, 1999, Procter & Gamble Health's market cap has increased from 9.75B to 100.54B, an increase of 931.68%. That is a compound annual growth rate of 9.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2025 | 100.54B | 15.64% |
| Dec 31, 2024 | 86.94B | 5.90% |
| Dec 29, 2023 | 82.10B | 23.12% |
| Dec 30, 2022 | 66.69B | -24.14% |
| Dec 31, 2021 | 87.91B | -22.28% |
| Dec 31, 2020 | 113.12B | 56.57% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.09T |
| Divi's Laboratories | 1.79T |
| Cipla | 1.22T |
| Apollo Hospitals Enterprise | 1.10T |
| Zydus Lifesciences | 987.17B |
| Mankind Pharma | 984.02B |
| Fortis Healthcare | 772.36B |
| Aurobindo Pharma | 672.92B |